Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.
for
Vitrectomy, Macular Pucker, Retinal Edema
Location: Elmhurst IL
Sponsor: Kovach Eye Institute
Sex: All
Age: 18+
Code: NCT04501367
Recruiting
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
for
Hereditary Angioedemas
Location: Saint Charles IL, Belleville NJ, Miami FL, Phoenix AZ,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT07001280
Recruiting
New
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
for
Pulmonary Disease, Chronic Obstructive
Location: Westchester IL, Indianapolis IN, Muncie IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40 - 70+
Code: NCT07759245
Phase 2, Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: New Lenox IL, Glenview IL, Merrillville IN, Carmel IN,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase 2, Recruiting
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
for
Aortic Stenosis, Severe
Location: New Lenox IL, Elk Grove Village IL, Evanston IL,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT05172960
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: New Lenox IL, Milwaukee WI, Columbus OH, Nashville TN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06561685
Phase 1, Recruiting
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New Lenox IL, Orland Park IL, Chicago IL, Munster IN,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05890352
Phase 2, Recruiting
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: New Lenox IL, Orland Park IL, Chicago IL, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05272384
Phase 1, Recruiting
PRE-ISPY Phase I/II Oncology Platform Program
for
HER2-positive Breast Cancer, Metastatic Cancer,
Location: New Lenox IL, Orland Park IL, Chicago IL,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT05868226
Phase 1, Phase 2, Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
for
Advanced Lung Neuroendocrine Tumor,
Location: New Lenox IL, Orland Park IL, Chicago IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04665739
Phase 2, Recruiting
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: New Lenox IL, Orland Park IL, Harvey IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07042295
Phase 2, Recruiting
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: New Lenox IL, Orland Park IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase 2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: New Lenox IL, Orland Park IL, Chicago IL,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: New Lenox IL, Orland Park IL, Maywood IL, Glenview IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase 2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: New Lenox IL, Orland Park IL, Maywood IL, Glenview IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for
Metastatic Dedifferentiated Liposarcoma,
Location: New Lenox IL, Orland Park IL, Chicago IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05711615
Phase 1, Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: New Lenox IL, Orland Park IL, Tinley Park IL, Harvey IL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase 1, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: New Lenox IL, Orland Park IL, Tinley Park IL, Harvey IL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer